Literature DB >> 21114994

Pharma-nutrition interface: the gap is narrowing.

Niki A Georgiou1, Johan Garssen, Renger F Witkamp.   

Abstract

The interaction between pharmacology and nutrition science is on the rise. Nutritional status is considered one of the important determinants of health and disease and several diseases of our time have a clear link with lifestyle factors including the diet. There is also increasing realization that a continuum between health and disease often exists without strict boundaries. Understanding the subtle interactions between genes, environment and homeostatic processes is the key in finding effective ways to prevent, treat or manage disease. Both pharmacologists and nutritionists are recognizing that most of the low hanging fruit has been picked, and that the one disease-one target-one drug (or nutrient) concept will provide fewer successes than it did in the past. Instead, complex multi-factorial diseases require multi-pathway understanding and multi-targeting approaches which will often result in compound combinations. Therapeutic synergy between foods and drugs does not necessarily mean that both have the same primary target. There are also examples of nutritional products that effectively contribute to the therapeutic regimen by improving the patients' general condition or by reducing side-effects of drugs. Examples of conditions and diseases that are highlighted in this review include the metabolic syndrome with its co-morbidities, immune-related diseases and HIV. With the aging population there are other fields emerging, including CNS-related diseases and cancer, where we will likely see an increased synergy between the two disciplines that seemed to have lost contact since the times of Hippocrates.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21114994     DOI: 10.1016/j.ejphar.2010.11.007

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  Risks of nutrigenomics and nutrigenetics? What the scientists say.

Authors:  T Hurlimann; V Menuz; J Graham; J Robitaille; M-C Vohl; B Godard
Journal:  Genes Nutr       Date:  2013-11-29       Impact factor: 5.523

2.  The marriage of nutrigenomics with the microbiome: the case of infant-associated bifidobacteria and milk.

Authors:  David A Sela; David A Mills
Journal:  Am J Clin Nutr       Date:  2014-01-22       Impact factor: 7.045

3.  Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice.

Authors:  Takashi Mori; Kavon Rezai-Zadeh; Naoki Koyama; Gary W Arendash; Haruyasu Yamaguchi; Nobuto Kakuda; Yuko Horikoshi-Sakuraba; Jun Tan; Terrence Town
Journal:  J Biol Chem       Date:  2012-01-04       Impact factor: 5.157

Review 4.  Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases.

Authors:  Saswata Talukdar; Jerrold M Olefsky; Olivia Osborn
Journal:  Trends Pharmacol Sci       Date:  2011-06-12       Impact factor: 14.819

Review 5.  Microbiota-dependent and -independent effects of dietary fibre on human health.

Authors:  Yang Cai; Jelle Folkerts; Gert Folkerts; Marcus Maurer; Saskia Braber
Journal:  Br J Pharmacol       Date:  2019-12-12       Impact factor: 8.739

6.  An update on the strategies in multicomponent activity monitoring within the phytopharmaceutical field.

Authors:  Johanna M Gostner; Oliver A Wrulich; Marcel Jenny; Dietmar Fuchs; Florian Ueberall
Journal:  BMC Complement Altern Med       Date:  2012-03-14       Impact factor: 3.659

7.  The Pharma-Nutritional Role of Antioxidant Phytochemicals in Health and Disease.

Authors:  Sergio Davinelli; Giovanni Scapagnini
Journal:  Antioxidants (Basel)       Date:  2022-05-29

8.  Fifteen Years of Regulating Nutrition and Health Claims in Europe: The Past, the Present and the Future.

Authors:  Alie de Boer
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

9.  An evaluation of the inhibitory effects against rotavirus infection of edible plant extracts.

Authors:  Karen Knipping; Johan Garssen; Belinda van't Land
Journal:  Virol J       Date:  2012-07-26       Impact factor: 4.099

10.  Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice.

Authors:  Takashi Mori; Naoki Koyama; Marie-Victoire Guillot-Sestier; Jun Tan; Terrence Town
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.